|
Colin Meyer, M.D. is the Director, Product Development of Reata and joined Reata as its second employee. Dr. Meyer�s primary role is to develop and implement strategies to move product candidates expeditiously through all stages of development. His duties include overseeing all preclinical development, determining relevant primary and surrogate endpoints for clinical studies, and developing clinical strategies for the drug candidates. Dr. Meyer received a B.S. in chemistry with specialization in biochemistry and a B.A. in biology from the University of Virginia. He received an M.D. from the University of Texas Southwestern Medical School and an M.B.A. from Southern Methodist University Cox School of Business. | 